Publisher
Kitakanto Medical Society
Reference10 articles.
1. 1. Akiyama H, Tanaka T, Maeno T, et al. Induction of vegf gene expression by retinoic acid through sp1-binding sites in retinoblastoma y79 cells. Invest Ophthalmol Vis Sci 2002; 43: 1367-1374.
2. 2. Akiyama H, Tanaka T, Doi H, et al. Visible light exposure induces vegf gene expression through activation of retinoic acid receptor-alpha in retinoblastoma y79 cells. Am J Physiol Cell Physiol 2005; 288: C913-920.
3. 3. Akiyama H, Tanaka T, Itakura H, et al. Inhibition of ocular angiogenesis by an adenovirus carrying the human von hippel-lindau tumor-suppressor gene in vivo. Invest Ophthalmol Vis Sci 2004; 45: 1289-1296.
4. 4. Akiyama H, Mohamedali KA, E Silva RL, et al. Vascular targeting of ocular neovascularization with a vascular endothelial growth factor121/gelonin chimeric protein. Mol Pharmacol 2005; 68: 1543-1550.
5. 5. Akiyama H, Kachi S, Silva RL, et al. Intraocular injection of an aptamer that binds pdgf-b: A potential treatment for proliferative retinopathies. J Cell Physiol 2006; 207: 407-412.